Advances in the design and development of SARS-CoV-2 vaccines.

Authors:
Peng XL; Cheng JS; Gong HL; Yuan MD; Zhao XH and 2 more

Journal:
Mil Med Res

Publication Year: 2021

DOI:
10.1186/s40779-021-00360-1

PMCID:
PMC8674100

PMID:
34911569

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mil Med Res

Abbreviation: Mil Med Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Military Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor im…
Dandia HY; Pillai MM; Sharma D and 7 more (2024) - Transparency Score: 3/6
Antimicrobial resistance crisis: could artificial intelligence be the solution?
Liu GY; Yu D; Fan MM and 4 more (2024) - Transparency Score: 3/6
Biomaterial-based mechanical regulation facilitates scarless wound healing with functional skin app…
Li YY; Ji SF; Fu XB and 2 more (2024) - Transparency Score: 3/6
CT whole lung radiomic nomogram: a potential biomarker for lung function evaluation and identificat…
Zhou TH; Zhou XX; Ni J and 16 more (2024) - Transparency Score: 3/6
Disentangling the effects of PTSD from Gulf War Illness in male veterans via a systems-wide analysi…
Sultana E; Shastry N; Kasarla R and 8 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors have applied for a Chinese patent for a bionic nanoparticle vaccine against COVID-19. Competing interests The authors have applied for a Chinese patent for a bionic nanoparticle vaccine against COVID-19."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (31900950)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025